|
Main
|
|
Note: This record shows only 22 elements of the WHO Trial Registration Data Set. To view changes that have been made to the source record, or for additional information about this trial, click on the URL below to go to the source record in the primary register. |
|
Register:
|
ClinicalTrials.gov |
|
Last refreshed on:
|
12 December 2020 |
|
Main ID: |
NCT03272321 |
|
Date of registration:
|
25/08/2017 |
|
Prospective Registration:
|
No |
|
Primary sponsor: |
|
|
Public title:
|
Influence of Oxytocin on Neurophysiological Responses to Live Faces
|
|
Scientific title:
|
Influence of Oxytocin on Neurophysiological Responses to Direct and Averted Gaze |
|
Date of first enrolment:
|
July 24, 2017 |
|
Target sample size:
|
56 |
|
Recruitment status: |
Completed |
|
URL:
|
https://clinicaltrials.gov/show/NCT03272321 |
|
Study type:
|
Interventional |
|
Study design:
|
Allocation: Randomized. Intervention model: Parallel Assignment. Primary purpose: Basic Science. Masking: Triple (Participant, Investigator, Outcomes Assessor).
|
|
Phase:
|
Phase 1/Phase 2
|
|
|
Countries of recruitment
|
|
Belgium
| | | | | | | |
|
Contacts
|
|
Name:
|
Kaat Alaerts, PhD |
|
Address:
|
|
|
Telephone:
|
|
|
Email:
|
|
|
Affiliation:
|
KU Leuven |
| | |
|
Key inclusion & exclusion criteria
|
Inclusion Criteria:
- right-handed
- male
- age between 18 and 35
- Normal or adjusted-to-normal vision (with lenses only)
- Dutch as mother tongue
Exclusion Criteria:
- not right-handed
- female
- age below 18 or above 35
- Need to wear glasses
- Dutch not as mother tongue
Age minimum:
18 Years
Age maximum:
35 Years
Gender:
Male
|
|
Health Condition(s) or Problem(s) studied
|
|
Oxytocin
|
|
Intervention(s)
|
|
Drug: Placebo
|
|
Drug: Oxytocin
|
|
Primary Outcome(s)
|
|
Change in skin conductance (type of electrodermal activity) response after oxytocin administration
[Time Frame: Average over several trials, baseline and 40 min after oxytocin or placebo administration]
|
|
Change in EEG asymmetry after oxytocin administration
[Time Frame: Average over several trials, baseline and 40 min after oxytocin or placebo administration]
|
|
Secondary Outcome(s)
|
|
Change in number of fixations to face regions after oxytocin administration
[Time Frame: Assesment over several trials, baseline and 40 min after oxytocin or placebo administration]
|
|
Change in duration of fixations to face regions after oxytocin administration
[Time Frame: Assesment over several trials, baseline and 40 min after oxytocin or placebo administration]
|
|
Secondary ID(s)
|
|
SingleOT_EEG-SC_S56327
|
|
Source(s) of Monetary Support
|
|
Please refer to primary and secondary sponsors
|
|
Results
|
|
Results available:
|
|
|
Date Posted:
|
|
|
Date Completed:
|
|
|
URL:
|
|
|
|